Establishing a CD8
+ T-cell-mediated immune correlate of protection in HIV disease is crucial to the development of vaccines designed to generate cell-mediated immunity.
Historically, neither the quantity nor breadth of the HIV-specific CD8 + T-cell response has correlated conclusively with protection. Here, we assess the quality of the HIVspecific CD8 + T-cell response by measuring five CD8 + T-cell functions (degranulation, IFNγ, MIP1β, TNFα, and IL2) simultaneously in chronically HIV-infected individuals and elite nonprogressors. We find that the functional profile of HIV-specific CD8 + Tcells in progressors is limited compared to that of nonprogressors, who consistently maintain highly functional CD8 + T-cells. This limited functionality is independent of HLA type and T-cell memory phenotype, is HIV-specific rather than generalized, and is not effectively restored by therapeutic intervention. While the total HIV-specific CD8 + T-cell frequency did not correlate with viral load, the frequency and proportion of the HIV-specific T-cell response with highest functionality inversely correlated with viral load in the progressors. Thus, rather than quantity or phenotype, the quality of the CD8 + T-cell functional response serves as an immune correlate of HIV disease progression and a potential qualifying factor for evaluation of HIV vaccine efficacy.
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CD8
+ T-cells play an important role in controlling HIV and SIV disease progression.
Evidence for this is based on several important observations and correlative studies.
First, their presence during SIV-infection leads to decreased viral replication and slower disease progression in rhesus macaques 1,2 . Second, resolution of acute viremia is coincident with a major expansion of HIV-specific CD8 + T-cells 3, 4 . Third, during primary and chronic infection, immunologic pressure mediated by SIV-and HIV-specific CD8 + T-cells is often manifested by viral escape mutation [5] [6] [7] [8] [9] . Finally, there are strong correlations between the expression of certain HLA class I alleles, lack of escape, and nonprogressive HIV infection 5, [10] [11] [12] [13] . Ultimately, the CD8 + T-cell response to HIV in most infected patients is insufficient to maintain durable control of HIV viral load and disease progression.
Despite extensive efforts, the definition of a CD8 + T-cell-mediated immune correlate of protection in HIV infection has proven elusive, because the precise mechanisms involved in CD8 + T-cell mediated control of most chronic viral infections, including HIV, are largely unknown. Three attributes of HIV-specific CD8 + T-cells could be involved in controlling HIV-1 viral replication: frequency, breadth of epitope recognition, and functional quality. MHC class I tetramer-based studies initially demonstrated that the frequency of HIV-specific CD8 + T-cells was inversely correlated with viral load 14 .
Subsequent correlative studies examining the frequency of functional HIV-specific CD8 + T-cell functions and HIV viral load have been inconclusive [15] [16] [17] [18] [19] . Similarly, the breadth of epitopes recognized by HIV-specific CD8 + T-cells does not correlate with control of viral replication or protection from disease progression 18 . How HIV-specific CD8 + T-cell response quality factors into the control of HIV remains unclear, but initial studies examining two CD8 + T-cell functions concordantly suggest an important relationship between response quality and immune control 20, 21 .
+ T-cells are capable of a multitude of functions, including cytolysis and production of several cytokines and chemokines. Therefore, measurement of only one or two CD8 + T-cell functions may not provide an adequate measure of CD8 + T-cell response quality.
Recent technological advancements in flow cytometry now permit the simultaneous
For personal use only. on April 12, 2017 . by guest www.bloodjournal.org From examination of multiple T-cell functions 22, 23 . We used polychromatic flow cytometry to assess simultaneously five CD8 + T-cell functions, including degranulation (CD107a mobilization 24 ), cytokine (IFNγ, TNFα, and IL2), and chemokine production (MIP1β) to determine if the HIV-specific CD8 + T-cell response quality is an important factor in HIV disease progression. We first examined a group of 79 HIV-infected individuals to establish the functional profile of HIV-specific CD8 + T-cells, and compared this to the CD8 + T-cell functional profile in a well-defined group of HIV-infected nonprogressors.
Our findings indicate that HIV-infected nonprogressors have a qualitatively different, and presumably superior, HIV-specific CD8 + T-cell response compared to that of HIVinfected progressors and that this response constitutes a correlate of protection and a target functional CD8 + T-cell response to induce with candidate HIV vaccines.
Results.

Concurrent measurement of five separate CD8 + T-cell functions
To measure the complexity of the HIV-specific T-cell response, we developed a flow cytometric assay to measure simultaneously and independently CD107a mobilization and IFNγ, MIP1β, TNFα, and IL2 production. Figure 1A shows representative data from an HIV-infected subject stimulated with overlapping HIV-gag peptides. In this subject, HIVgag specific CD8 + T-cells eliciting each of the five functions were measurable (CD107a, 3.5%; IFNγ, 2.5%; MIP1β, 4.6%, IL2, 0.2%; TNFα, 0.6%). The full complexity of the response was then examined using a Boolean gating algorithm, yielding 32 unique response patterns comprising every combination of the five individual measurements ( Figure 1D ). The frequency of each individual response patterns was then assessed, and the contribution of each combination towards the total response determined.
Hierarchy of the HIV-specific CD8 + T-cell functional response
Using this panel, we assessed the HIV-specific CD8 + T-cell response functionality by measuring responses against the total HIV genome in 79 chronically infected individuals (termed "progressors", Table 1 ;see Materials and Methods for selection criteria). Overall, MIP1β dominated the HIV-specific CD8 + T-cell response for every HIV antigen (P<0.001; Figure 1B ). CD107a expression and IFNγ production were the next highest responses, followed by TNFα, and finally IL2 production. In some subjects, cells expressing IFNγ accounted for only 60% of the response, and in no subject was IFNγ the most highly expressed function (data not shown). This indicates that measurement of only IFNγ underestimates the total HIV-specific CD8 + T-cell frequency.
We next addressed whether by measuring additional CD8 + T-cell functions beyond IFNγ a relationship between HIV-specific CD8 + T-cell frequency and viral load might be identified. No relationship between the HIV-specific CD8 + T-cell frequency, either in total ( Figure 1C ) or to individual HIV antigens (data not shown), and viral load was
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We examined the functional hierarchy of the HIV-specific CD8 + T-cell response in the progressors to HIV Gag, as shown in Figure 1D . 
HIV-infected non-progressors maintain a higher degree of CD8 + T-cell functionality
Having observed consistent patterns of limited functionality in response to HIV antigens in the progressors, we hypothesized that nonprogressive HIV infection may be associated with a qualitatively different CD8 + T-cell functional profile. We therefore performed a similar analysis of HIV-specific CD8 + T-cells in nine HIV-infected nonprogressors (Table 1 ). Figure 2A shows the response to HIV-Gag in a representative HIV-infected 
Relationship between functionality and viral load
Having observed enhanced functionality in the nonprogressors, we revisited the We further tested the importance of the 5+ HIV-specific CD8 + T-cell response by creating a linear regression model to predict viral load as a function of both CD4 count and the 5+ HIV-specific CD8 + T-cell response frequency (sum of Gag, Nef, and Envspecific 5+ responses). After controlling for CD4 count, we found that the frequency of the 5+ response strongly correlated with viral load (P<0.0001, r 2 =0.39, slope=-19.6).
Similar relationships were observed when testing this model using the individual 5+ response frequencies specific for Gag, Env, or Nef, but not Pol or TRVVV (data not shown). Thus, the 5+ HIV-specific CD8 + T-cell response frequency is predictive of viral load independent of CD4 T-cell count. . We observed similar phenotypic heterogeneity in responses positive for all functions except IL2 ("4+IL2"; orange contours, Figure 4D ). 4+IL2 -CEF-specific cells in progressor C2 also were CD45RO + CD27
+ , but greatly skewed towards CD57 expression. In the same subject, 4+IL2 -TRVVV-specific cells could be subdivided into multiple populations based on CD45RO, CD27, and CD57 levels.
Similar variability was observed in the 4+IL2 -Gag and Nef-specific CD8 + T-cells in subject NP8. These results demonstrate that memory phenotype is not necessarily predictive of functionality, and that the presence of the 5+ function cells in the For Similar to a recent report 22 The most dramatic difference in functionality that we observed was the loss of the 5+ population in the progressors. Indeed, we find that both the frequency and proportion of the 5+ population correlates inversely with viral load in the progressors. Thus, the total magnitude of the HIV-specific response is not necessarily associated with viral control;
instead, the magnitude of specific functional subpopulations within the total response is associated with control of viral load.
The 5+ functional population is likely of significant immunological importance, as it represents up to 25% of the total response to CMV, EBV, and influenza, viral infections thought to be effectively controlled by CD8 + T-cells. This population could directly eliminate virally infected cells (assuming it expresses or upregulates perforin) and suppress viral replication, while maintaining itself without CD4 + T-cell help through autocrine production of IL2. This latter ability may be especially important in the setting of diminished CD4 + T-cell help in HIV infection, as was recently suggested 25 .
Alternatively, these cells may represent a self-renewing progenitor population of antigenspecific CD8 + T-cells responsible for long-term maintenance of effector CD8 + T-cells, without any direct antiviral ability themselves. Because these cells cannot simply be defined by the commonly used cell surface memory phenotyping markers CD27, CD45RO, and CD57, further experiments will be necessary to determine their exact phenotypic lineage and role in immunological control.
We find that diminished HIV-specific CD8 + T-cell functionality in progressors is not an Only patients not receiving antiretroviral therapy were recruited, although some subjects had a previous history of HAART ( Table 1 ). All assays using this group were performed blinded to viral load, CD4 count, and disease history. The viral load ranged from <50 to 708,000 copies/ml, and the CD4 counts from 4 to 1428 cells/mm 3 . Thus, these subjects represent the normal spectrum of disease progression expected in untreated HIV
infection. The precise infection time in these individuals is unknown. Because these subjects are considered a representative sample of HIV infected subjects, as many as ~5%
of the subjects may be nonprogressors. For example, subject C3 appears to fit our definition of a nonprogressor; however, there are not supporting longitudinal data to be sure this subject fits these criteria. Several subjects subsequently initiated HAART following the initial sampling date; viral load in these individuals dropped below the limit of detection (<50 copies/ml), with one exception (70 copies/ml). Samples from these subjects were collected approximately 6 months-1 year following inception of HAART.
A second group consisted of extensively characterized HIV-infected nonprogressors 11, 33, 34 (NP1-9) recruited at the National Institutes of Health The criteria for nonprogression were durable maintenance of normal CD4 + T-cell counts/ratio and viral load ≤ 125 RNA copies/ml in the absence of therapeutic intervention or opportunistic infections for duration of infection. All subjects gave informed consent as required.
Peripheral blood mononuclear cells (PBMC) were isolated by Hypaque-Ficoll (Pharmacia, Uppsala, Sweden) density centrifugation, and were frozen at -140°C at 10- Peptides. Peptides (15mers overlapping by 11) corresponding to full length HIV-1 gag, pol, env, nef, tat, rev, vif, vpr, and vpu were used at 2 μg/ml each peptide. The gag, pol, env, and nef peptides corresponded to the HXBc2/Bal R5 chimeric strain, and the tat, rev, vif, vpr, and vpu were clade B consensus sequence (NIH AIDS
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Reagent Program). All peptides were synthesized as free acids, and were greater than 80% pure. Lyophilized peptides were reconstituted to 100 mg/ml in 100% DMSO for the peptide mixes. Five mixes were prepared, one each for full-length gag, pol, env, and nef; tat, rev, vif, vpr, and vpu peptides were combined into one mix (TRVVV). Optimized peptides derived from CMV, EBV, and influenza were the kind gift of Dr. Guido Ferrari Cell stimulation and staining. Purified PBMC were thawed, resuspended to 2×10 6 cells/ml in complete RPMI media (RPMI 1640 supplemented with 10% heat inactivated fetal calf serum, 100 U/ml penicillin, 100 μg/ml streptomycin sulfate, and 1.7 mM sodium glutamate) and rested overnight at 37°C with DNAse I (10U/ml, Roche Diagnostics, Indianapolis, IN). The following morning, the PBMC were examined for viability by Trypan blue exclusion (typically ≥90% viable) and adjusted to 1×10 6 cells/ml. Costimulatory antibodies (αCD28 and 49d, 1μg/ml, BD Biosciences), monensin (Golgistop, 0.7μl/ml, BD Biosciences), Brefeldin A (10μg/ml, Sigma-Aldrich), and αCD107a-Alexa 680 (pre-titered volume) were added, and the cells aliquoted at 1 ml to each tube containing 5 μl of each peptide mix. An unstimulated and positive control (Staphylococcus Enterotoxin B, 1 μg/ml, Sigma-Aldrich) were included in each assay.
Cells were incubated for 5.5 hours at 37°C. Following incubation, the cells were washed Respective P values are shown in the upper right of each graph. In the graphs, frequency refers to the magnitude of the antigen specific response with a specific functional profile within the total CD8 pool, and percent refers to the proportion of the total antigen specific For personal use only. on April 12, 2017 . by guest www.bloodjournal.org From
